Gregory Kearns, PharmD, PhD, has been selected as the recipient of the 2008 Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics.

 

Dr. Kearns is Chairman of Pediatric Medical Research at the Children's Mercy Hospital and the Marion Merrell Dow/Missouri Chair in Pediatric Medical Research at the University of Missouri-Kansas City School of Medicine.

 

He received his Bachelor of Science degree from the St. Louis College of Pharmacy (1977) and his PharmD from the University of Cincinnati (1977). He completed his Residency at Cincinatti Children's Medical Center in 1979 and a postdoctoral fellowship at the Louisiana State University in 1983. Dr. Kearns continued his education, earning a PhD in Medicine and Clinical Pharmacology from Erasmus University in Rotterdam, Netherlands.

 

Dr. Kearns' research interests include metabolite-mediated cytotoxicity as relates to the production of adverse drug reactions, developmental pharmacogenetics and pharmacokinetics, functional pharmacogenomics, and pharmacokinetic-pharmacodynamic modeling .

Dr. Kearns is a member of  the Society for Pediatric Research, American Association of Pharmaceutical Scientists (charter member), Pacific Rim Society for Pharmacogenetics (charter member), American College of Clinical Pharmacology, and American Society for Clinical Pharmacology and Therapeutics.

 

Dr. Kearns has received many significant award, including the Distinguished Investigator Award from the American College of Clinical Pharmacology and is a recipient of the Roy Patterson Distinguished Lectureship from the American Academy of Allergy, Asthma and Clinical Immunology. He is widely published and is a past president of ASCPT.

 

•  del.icio.us •  digg •  facebook